"Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib." by Christine Saraceni

Selected Works of Gary A. Stopyra, MD

Follow Contact

Article

Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib.

J Thorac Oncol

Christine Saraceni, Lehigh Valley Health Network
P. Mark Li, MD, PhD, Lehigh Valley Health Network
Justin F Gainor
Gary A Stopyra, MD, Lehigh Valley Health Network
Eliot L Friedman, MD, Lehigh Valley Health Network

Link Find in your library

Publication/Presentation Date

7-1-2015

Disciplines

Hematology,
Medical Sciences and
Medicine and Health Sciences

PubMedID

26134230

Document Type

Article

Citation Information

Saraceni, C., Li, P. M., Gainor, J. F., Stopyra, G. A., & Friedman, E. L. (2015). Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib. Journal Of Thoracic Oncology: Official Publication Of The International Association For The Study Of Lung Cancer, 10(7), 1116-1117. doi:10.1097/JTO.0000000000000409